Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain

Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain

Chronic pain affects ~10–20% of the U.S. population with an estimated annual cost of $600 billion, the most significant economic cost of any disease to-date. Neuropathic pain is a type of chronic pain that is particularly difficult to manage and leads to significant disability and poor quality of li...

Full description

Bibliographic Details
Main Authors: Monica M. Diaz, Jacob Caylor, Irina Strigo, Imanuel Lerman, Brook Henry, Eduardo Lopez, Mark S. Wallace, Ronald J. Ellis, Alan N. Simmons, John R. Keltner
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pain Research
Subjects:
pain
biomarker
neuropathic
endocannabinoid
inflammation
opiate
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2022.869215/full

Internet

https://www.frontiersin.org/articles/10.3389/fpain.2022.869215/full

Similar Items